Anavex to Participate in Mizuho Therapeutics Conference

Conference to Feature Companies with Focus on Alzheimer’s, Parkinson’s and other Neurological Diseases NEW YORK, NY – September 14, 2016 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical...

Anavex Reports Fiscal Third Quarter 2016 Financial Results

New York, NY – August 11, 2016 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and...

Anavex to Present at the 2016 Rett Syndrome Symposium

NEW YORK – June 23, 2016 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL) a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental...